Conformis, Inc. provided second quarter revenue guidance for the financial year ending December 31, 2023. For the period, the company expects second quarter product revenue to be in the range of $11.0 million to $13.0 million.
Conformis, Inc.
Equities
CFMS
US20717E2000
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
+10.86% | 13TCr | |
-5.70% | 1.13TCr | |
+4.17% | 912.22Cr | |
-21.47% | 474.63Cr | |
+8.77% | 345.34Cr | |
-6.03% | 288.74Cr | |
-12.05% | 207.12Cr | |
-7.83% | 205.48Cr | |
-22.84% | 179.55Cr |